FDA Approved: TRANYLCYPROMINE — Original Application (Novitium Pharma LLC)

View source ↗

Summary

FDA approved Novitium Pharma LLC's original ANDA for Tranylcypromine, a generic monoamine oxidase inhibitor for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Tranylcypromine (tranylcypromine)

Snippet

ORIG AP for TRANYLCYPROMINE (TRANYLCYPROMINE)